1. Sul YT, Johansson C, Albrektsson T. Which surface properties enhance bone response to implants? Comparison of oxidized magnesium, TiUnite, and Osseotite implant surfaces. Int J Prosthodont. 2006; 19:319–328.
2. Zreiqat H, Howlett CR, Zannettino A, Evans P, Schulze-Tanzil G, Knabe C, Shakibaei M. Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants. J Biomed Mater Res. 2002; 62:175–184.
3. Sul YT, Johansson P, Chang BS, Byon ES, Jeong Y. Bone tissue responses to Mg-incorporated oxidized implants and machine-turned implantsin the rabbit femur. J Appl Biomater Biomech. 2005; 3:18–28.
4. Sul YT, Johansson CB, Kang Y, Jeon DG, Albrektsson T. Bone reactions to oxidized titanium implants with electrochemical anion sulphuric acid and phosphoric acid incorporation. Clin Implant Dent Relat Res. 2002; 4:78–87.
5. Maitz MF, Poon RW, Liu XY, Pham MT, Chu PK. Bioactivity of titanium following sodium plasma immersion ion implantation and deposition. Biomaterials. 2005; 26:5465–5473.
6. Sul YT, Johansson C, Byon E, Albrektsson T. The bone response of oxidized bioactive and non-bioactive titanium implants. Biomaterials. 2005; 26:6720–6730.
7. Cho LR, Kim DG, Kim JH, Byon ES, Jeong YS, Park CJ. Bone response of Mg ion-implanted clinical implants with the plasma source ion implantation method. Clin Oral Implants Res. 2010; 21:848–856.
8. Sammons RL, Lumbikanonda N, Gross M, Cantzler P. Comparison of osteoblast spreading on microstructured dental implant surfaces and cell behaviour in an explant model of osseointegration. A scanning electron microscopic study. Clin Oral Implants Res. 2005; 16:657–666.
9. Park JW, Kim YJ, Jang JH, Song H. Osteoblast response to magnesium ion-incorporated nanoporous titanium oxide surfaces. Clin Oral Implants Res. 2010; 21:1278–1287.
10. Takebe J, Itoh S, Okada J, Ishibashi K. Anodic oxidation and hydrothermal treatment of titanium results in a surface that causes increased attachment and altered cytoskeletal morphology of rat bone marrow stromal cells in vitro. J Biomed Mater Res. 2000; 51:398–407.
11. Samee N, Geoffroy V, Marty C, Schiltz C, Vieux-Rochas M, Levi G, de Vernejoul MC. Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling. Am J Pathol. 2008; 173:773–780.
12. Tadic T, Dodig M, Erceg I, Marijanovic I, Mina M, Kalajzic Z, Velonis D, Kronenberg MS, Kosher RA, Ferrari D, Lichtler AC. Overexpression of Dlx5 in chicken calvarial cells accelerates osteoblastic differentiation. J Bone Miner Res. 2002; 17:1008–1014.
13. Ajroud K, Sugimori T, Goldmann WH, Fathallah DM, Xiong JP, Arnaout MA. Binding Affinity of Metal Ions to the CD11b A-domain Is Regulated by Integrin Activation and Ligands. J Biol Chem. 2004; 279:25483–25488.
14. Zreiqat H, Valenzuela SM, Nissan BB, Roest R, Knabe C, Radlanski RJ, Renz H, Evans PJ. The effect of surface chemistry modification of titanium alloy on signalling pathways in human osteoblasts. Biomaterials. 2005; 26:7579–7586.
15. Olivares-Navarrete R, Raz P, Zhao G, Chen J, Wieland M, Cochran DL, Chaudhri RA, Ornoy A, Boyan BD, Schwartz Z. Integrin alpha2beta1 plays a critical role in osteoblast response to micron-scale surface structure and surface energy of titanium substrates. Proc Natl Acad Sci U S A. 2008; 105:15767–15772.
16. Keselowsky BG, Wang L, Schwartz Z, Garcia AJ, Boyan BD. Integrin alpha(5) controls osteoblastic proliferation and differentiation responses to titanium substrates presenting different roughness characteristics in a roughness independent manner. J Biomed Mater Res A. 2007; 80:700–710.
17. Wilson SR, Peters C, Saftig P, Brömme D. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption. J Biol Chem. 2009; 284:2584–2592.
18. Flanagan AM, Massey HM, Wilson C, Vellodi A, Horton MA, Steward CG. Macrophage colony-stimulating factor and receptor activator NF-kappaB ligand fail to rescue osteoclastpoor human malignant infantile osteopetrosis in vitro. Bone. 2002; 30:85–90.
19. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003; 423:337–342.
20. Burgess TL, Qian Y, Kaufman S, Ring BD, Van G, Capparelli C, Kelley M, Hsu H, Boyle WJ, Dunstan CR, Hu S, Lacey DL. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol. 1999; 145:527–538.